Tuesday, May 4
Programming presented by Pharmaceutical Executive Magazine
9:00 am
Registration and Post-marketing Compliance: Enlightened Regulation or Accelerated Bureaucracy?
David Verbraska, VP, Worldwide Regulatory Policy, Pfizer Inc.
10:00 am
Leveraging the Therapeutic Promise of Biotech: New Pathways in Oncology
Stephen Rhind, SVP, Corporate Development, S*Bio Pte Ltd, Singapore
11:00 am
Partnering for Success on Neglected Diseases: How Far Have We Come?
Dr. Melinda Moree, CEO, Bioventures for Global Health
Dr. Jean-Pierre Paccaud, Director Business Development, Drugs for Neglected Disease Initiative [DNDi]
2:00 pm
Biotech Strategy: NicOx’s Global Platform for Growth
Sanjiv Sharma, VP Commercial, NicOx Inc.
3:00pm
Data, Evidence, Value: the Elusive Quest for Market Access
Daniel Todd, Senior Director, Health Policy, EMD Serono Inc |
Wednesday, May 5
Programming presented by BioPharm International
10:30 am
Environmental Monitoring, Today and Tomorrow
Jeanne Moldenhauer, Vice President, Excellent Pharma Consulting
11:00 am
Quality by Design: Where We Go From Here
Ranjit Deshmukh, Sr. Director, MedImmune, and Chair, PQLI Biotech Team
11:30 am
How to Achieve Statistical Process Control
John Hyde, Founder and Chairman, Hyde Engineering + Consulting
12:00 pm
How Outsourcing Can Accelerate Early CMC Development
Jim Miller, President, PharmSource Information Services, with Susan Dana Jones, PhD, Vice President and Senior Consultant, BioProcess Technology Consultants
1:00 pm
Process Robustness: The Key to Successful Technical Transfer
William Schmidt, Pharma Sector Head, Tunnell Consulting
1:30 pm
The State of the Art of Mab Development and Manufacturing
Howard Levine, PhD, President, Bioprocess Technology Consultants
2:00 pm
Advances in Vaccine Characterization
Vincent E. Turula, Jr., PhD, Pfizer BioTherapeutics Pharmaceutical Sciences
2:30 pm
Faster, Cheaper Vaccine Manufacturing
Andrew Sheldon, President and CEO, Medicago
3:00 pm
Opportunities in Biosimilars
Michael Kamarck, PhD, President, Merck BioVentures and Senior Vice President, Biologics and Vaccines
4:00 pm – Programming presented by Pharmaceutical Executive Magazine
Global Competitiveness in Biotech: Spain Sets a Strategy
Jose Maria Fernandez-Sousa, Chairman, Zeltia Group |